Skip to main content
Top
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Original Article

Socioeconomic impact of ankylosing spondylitis in Morocco

Authors: Hanan Rkain, Fadoua Allali, Aziza Bentalha, Noufissa Lazrak, Redouane Abouqal, Najia Hajjaj-Hassouni

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

The goal of this study was to determine the impact of ankylosing spondylitis (AS) on the socioeconomic well-being of Moroccan patients. One hundred (100) consecutive AS patients (71 men, 29 women) were included. The socioeconomic consequences were studied by measuring direct costs, indirect costs (consequences on work capacity), and intangible costs (social impact) of AS. The mean age at AS onset was 26.85 years ± 11.71 (7–64). The mean disease duration of AS was 12.05 years ± 8.32 (0.5–39). Financial difficulties due to AS were observed in 82% of the patients. In 28% of them, these conditions explained a bad observance to treatments. In 14% of the cases, they led children to leave school to support their handicapped parents. Work disability occurred in 22.9% of initially employed patients. Withdrawal from work was correlated to bad social conditions at work, higher scores of Bath ankylosing spondylitis functional index (BASFI), and absence of adherence to a social security system. Sexual problems were present in 64.2% of the patients and were correlated to higher scores of BASFI. There were also disturbances in housekeeping (65.8%) and in leisure time activities (72.2%). Patients received a financial and a psychological familial support in, respectively, 66 and 87% of the cases. Despite the great familial support, Moroccan AS patients suffer from important socioeconomic consequences because of the illness, the bad socioeconomic conditions, the insufficiency of state help, and the social security problems.
Literature
1.
2.
go back to reference Boonen A, Severens JL (2002) Ankylosing spondylitis: what is the cost to society, and can it be reduced? Best Pract Res Clin Rheumatol 16(4):691–705CrossRefPubMed Boonen A, Severens JL (2002) Ankylosing spondylitis: what is the cost to society, and can it be reduced? Best Pract Res Clin Rheumatol 16(4):691–705CrossRefPubMed
3.
go back to reference Boonen A (2002) Socioeconomic consequences of ankylosing spondylitis. Clin Exp Rheumatol 20(suppl 28):S23–S26PubMed Boonen A (2002) Socioeconomic consequences of ankylosing spondylitis. Clin Exp Rheumatol 20(suppl 28):S23–S26PubMed
4.
go back to reference Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771CrossRefPubMed Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771CrossRefPubMed
5.
go back to reference Wordsworth BP, Mowat AG (1986) A review of 100 patients with AS with particular reference to socio-economic effects. Br J Rheumatol 25(2):175–180CrossRefPubMed Wordsworth BP, Mowat AG (1986) A review of 100 patients with AS with particular reference to socio-economic effects. Br J Rheumatol 25(2):175–180CrossRefPubMed
6.
go back to reference Van der Linden S, Vankenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed Van der Linden S, Vankenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed
7.
go back to reference Les indicateurs sociaux 2005. Ministère chargé de la population. Direction de la statistique Les indicateurs sociaux 2005. Ministère chargé de la population. Direction de la statistique
8.
go back to reference Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in AS: the development of the Bath AS functional index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in AS: the development of the Bath AS functional index. J Rheumatol 21:2281–2285PubMed
9.
go back to reference Garret S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in AS: the Bath AS disease activity index. J Rheumatol 21:2286–2291 Garret S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in AS: the Bath AS disease activity index. J Rheumatol 21:2286–2291
10.
go back to reference Boonen A, Van der Heijde D, Landewe R et al (2002) Work status and productivity costs due to AS, comparison of three European countries. Ann Rheum Dis 61:429–437CrossRefPubMedPubMedCentral Boonen A, Van der Heijde D, Landewe R et al (2002) Work status and productivity costs due to AS, comparison of three European countries. Ann Rheum Dis 61:429–437CrossRefPubMedPubMedCentral
11.
12.
go back to reference Barlow JH, Wright CC, Williams B et al (2001) Work disability among people with AS. Arthritis Rheum 45(5):424–429CrossRefPubMed Barlow JH, Wright CC, Williams B et al (2001) Work disability among people with AS. Arthritis Rheum 45(5):424–429CrossRefPubMed
13.
go back to reference Boonen A, Chorus A, Miedema et al (2001) Employment work disability and work day lost in patients with AS: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358CrossRefPubMedPubMedCentral Boonen A, Chorus A, Miedema et al (2001) Employment work disability and work day lost in patients with AS: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358CrossRefPubMedPubMedCentral
14.
go back to reference Ward MM, Kuzis S (2001) Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol 28(2):315–321PubMed Ward MM, Kuzis S (2001) Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol 28(2):315–321PubMed
15.
go back to reference Guillemin F, Briancon S, Pourel J et al (1990) Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 33(7):1001–1006CrossRefPubMed Guillemin F, Briancon S, Pourel J et al (1990) Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 33(7):1001–1006CrossRefPubMed
16.
go back to reference Boonen A, Chorus A, Landewe R et al (2002) Manuel jobs increase the risk of patients with AS withdrawing from the labour force, also when adjusted for job related withdrawal in the general population. Ann Rheum Dis 61:658CrossRefPubMedPubMedCentral Boonen A, Chorus A, Landewe R et al (2002) Manuel jobs increase the risk of patients with AS withdrawing from the labour force, also when adjusted for job related withdrawal in the general population. Ann Rheum Dis 61:658CrossRefPubMedPubMedCentral
17.
go back to reference Rkain H, Allali F, Jroundi I, Hajjaj-Hassouni N (2006) Socioeconomic impact of rheumatoid arthritis in Morocco. Joint Bone Spine 73:278–283CrossRefPubMed Rkain H, Allali F, Jroundi I, Hajjaj-Hassouni N (2006) Socioeconomic impact of rheumatoid arthritis in Morocco. Joint Bone Spine 73:278–283CrossRefPubMed
18.
go back to reference Hill J, Bird H, Thorpe R (2003) Effects of rheumatoid arthritis on sexual activity and relationships. Rheumatology 42:280–286CrossRefPubMed Hill J, Bird H, Thorpe R (2003) Effects of rheumatoid arthritis on sexual activity and relationships. Rheumatology 42:280–286CrossRefPubMed
19.
go back to reference Hajjaj-Hassouni N, Maetzel A, Dougados M, Amor B (1993) Comparaison des malades examinés pour spondylarthropathie en France et au Maroc. Rev Rhum (Ed Fr) 60(6):420–425 Hajjaj-Hassouni N, Maetzel A, Dougados M, Amor B (1993) Comparaison des malades examinés pour spondylarthropathie en France et au Maroc. Rev Rhum (Ed Fr) 60(6):420–425
20.
go back to reference Pirildar T, Muezzinoglu T, Pirildar S (2004) Sexual function in ankylosing spondylitis: a study of 65 men. J Urol 171(4):1598–1600CrossRefPubMed Pirildar T, Muezzinoglu T, Pirildar S (2004) Sexual function in ankylosing spondylitis: a study of 65 men. J Urol 171(4):1598–1600CrossRefPubMed
21.
go back to reference Dagfinrud H, Mengshoel AM, Hagen KB et al (2004) Health status of patients with AS: a comparison with the general population. Ann Rheum Dis 63:1605–1610CrossRefPubMedPubMedCentral Dagfinrud H, Mengshoel AM, Hagen KB et al (2004) Health status of patients with AS: a comparison with the general population. Ann Rheum Dis 63:1605–1610CrossRefPubMedPubMedCentral
22.
go back to reference Ward MM (1999) Health-related Quality of life in AS: a survey of 175 patients. Arthritis Care Res 12(4):247–255CrossRefPubMed Ward MM (1999) Health-related Quality of life in AS: a survey of 175 patients. Arthritis Care Res 12(4):247–255CrossRefPubMed
Metadata
Title
Socioeconomic impact of ankylosing spondylitis in Morocco
Authors
Hanan Rkain
Fadoua Allali
Aziza Bentalha
Noufissa Lazrak
Redouane Abouqal
Najia Hajjaj-Hassouni
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0622-1

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.